Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent progress in targeting KRAS mutant cancers with covalent G12C-specific inhibitors
Lala S. Rathod, Pratap S. Dabhade, Santosh N. Mokale
Drug Discovery Today (2023) Vol. 28, Iss. 5, pp. 103557-103557
Closed Access | Times Cited: 18

Showing 18 citing articles:

Recent advances of anti-angiogenic inhibitors targeting VEGF/VEGFR axis
Lei Wang, Wang‐Qing Liu, Sylvain Broussy, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 36
KRASG12C mutant lung adenocarcinoma: unique biology, novel therapies and new challenges
Judit Moldvay, József Tı́már
Pathology & Oncology Research (2024) Vol. 29
Open Access | Times Cited: 5
An overview of recent advancements in small molecules suppression of oncogenic signaling of K-RAS: an updated review
Ahmed Sabt, Haytham O. Tawfik, Eman F. Khaleel, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 3
Protein Haptenation and Its Role in Allergy
Maja Aleksić, Xiaoli Meng
Chemical Research in Toxicology (2024) Vol. 37, Iss. 6, pp. 850-872
Open Access | Times Cited: 3
Progress in the development of ERK1/2 inhibitors for treating cancer and other diseases
Lena Grogan, Paul Shapiro
Advances in pharmacology (2024), pp. 181-207
Closed Access | Times Cited: 2
KRAS depletion suppresses ferroptosis and affects Hippo pathway in cataract
Hongda Jiang, Yinggui Yu, Yu Yan
General Physiology and Biophysics (2024) Vol. 43, Iss. 03, pp. 243-253
Open Access | Times Cited: 2
Can Machine Learning Overcome the 95% Failure Rate and Reality that Only 30% of Approved Cancer Drugs Meaningfully Extend Patient Survival?
Duxin Sun, Christian Macedonia, Zhigang Chen, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 2
Genomic Landscape of Endometrial, Ovarian, and Cervical Cancers in Japan from the Database in the Center for Cancer Genomics and Advanced Therapeutics
Qian Xi, Hidenori Kage, Miho Ogawa, et al.
Cancers (2023) Vol. 16, Iss. 1, pp. 136-136
Open Access | Times Cited: 5
In Silico Identification of Dysregulated miRNAs Targeting KRAS Gene in Pancreatic Cancer
Asbiel Felipe Garibaldi-Ríos, Luis E. Figuera, Guillermo Moisés Zúñiga‐González, et al.
Diseases (2024) Vol. 12, Iss. 7, pp. 152-152
Open Access | Times Cited: 1
Combination of farnesyl-transferase inhibition with KRAS G12D targeting breaks down therapeutic resistance in pancreatic cancer
Eszter Molnár, Marcell Baranyi, Krisztina Andrea Szigeti, et al.
Pathology & Oncology Research (2024) Vol. 30
Open Access | Times Cited: 1
What’s been Hapten-ing over the last 88 years?
Paul Thomson, Sean Hammond, Xiaoli Meng, et al.
Medicinal Chemistry Research (2023) Vol. 32, Iss. 9, pp. 1950-1971
Open Access | Times Cited: 3
Hetero-tricyclic Compounds as KRAS Inhibitors for Treating Cancer
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 9, pp. 1154-1155
Open Access | Times Cited: 2
KRAS inhibitors in drug resistance and potential for combination therapy
Lala S. Rathod, Nikhil S. Sakle, Santosh N. Mokale
Tumori Journal (2024)
Closed Access
Covalent Inhibitors of MAP Kinases
Surya K. De
Drug design and discovery (2024), pp. 159-189
Closed Access
Novel Tricyclic Compounds as KRAS Inhibitors for Treating Cancer
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 5, pp. 555-556
Open Access | Times Cited: 1
Novel Quinoline Compounds as KRAS Inhibitors for Treating Cancer
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 6, pp. 707-708
Open Access | Times Cited: 1
Genomic landscape of endometrial, ovarian and cervical cancers in Japan from database in the Center for Cancer Genomics and Advanced Therapeutics
Qian Xi, Hidenori Kage, Miho Ogawa, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Novel Pyrazoloquinoline Compounds as KRAS Inhibitors for Treating Cancer
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 8, pp. 1045-1046
Open Access
Page 1

Scroll to top